[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BiopharmIQ "1/ 🧵 Biotech Stock News 10/07 @ Open $LXEO XX% Progress in FDA Discussions & Data $TELO XX% New Findings in Prostate Cancer Model $KZIA XX% Collaboration & In-Licensing Agreement $ANIX XX% Completion of Final Patient Visit $DBVT XX% Sale of $XX million ADSs $DYN XX% One-Year Clinical Data for DM1 $CLLS X% Data on Non-Viral Gene Therapy $OGEN X% Strategic Partnership to Accelerate Pipeline $AVIR X% New Data on Hepatitis C Treatment $ABUS X% Four Abstracts Accepted for AASLD 2025 $MAIA X% Initiate Digital Asset Treasury Strategy $GALT X% Present at AASLD Liver Meeting 2025 $EPIX 2%"
X Link @BiopharmIQ 2025-10-07T15:57Z 27.3K followers, 8158 engagements

"$OVID up XX% 📈 OV329 shows strong Ph1 results. Favorable safety no eye issues. Now advancing to Ph2a. Initiate in Q2 2026 and completion in mid-2027 Don't miss out on future Big Movers Access our FREE Big Mover Report 👇"
X Link @BiopharmIQ 2025-10-03T15:47Z 27.3K followers, 1370 engagements

"🧬 Biotech Weekly News - Largest single-day stock moves during the week ending 10/10/25 📈 $SPRB 1378% Breakthrough Therapy Designation $LPTX XX% $58.88M Private Placement $LXEO XX% FDA Discussions Progress & Data $TELO XX% New Findings in Prostate CA Model $ANIX XX% Completion Final Patient Visit 📉 $SKYE -XX% Topline Ph2a Data Reported $HUMA -XX% Pricing of $XX Million Offering $BMEA -XX% 52-Wk Results in Diabetes Study $ANVS -XX% $6M Direct Offering $CABA -XX% Rese-cel Data @ ESGCT'25"
X Link @BiopharmIQ 2025-10-10T22:41Z 27.3K followers, 13.9K engagements

"📣 Biotech Stock News 10/09 @ Open $TELO XX% Discovery of Telomir-1 in Cancer Cells $AKRO XX% Acquisition for up to $XXX Billion $NGNE XX% Positive Regulatory Update for NGN-401 $CDTX XX% FDA Breakthrough Therapy Designation for CD388 $APGE X% Pricing of $XXX Million Offering $SXTP X% Unveils Chronic Babesiosis Clinical Trial $ANVS X% Novel Biomarker Data in Alzheimer's $WGS X% Launch of Autism Partnership Program $PTHS X% Launches Moms Against Molluscum Movement $ADIL X% Partners for Precision Medicine Testing $CPRX X% Presentations at Upcoming Scientific Conferences $AMIX X% U.S. Patent for"
X Link @BiopharmIQ 2025-10-09T15:50Z 27.3K followers, 9764 engagements

"🧬 Biotech Stock News 10/14 Brought to you by Barb On the rise 📈 $ATXS XX% $RCKT XX% $GNPX XX% Under pressure 📉 $NCNA -X% $VOR -X% $CADL -XX% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-10-14T17:47Z 27.3K followers, 3901 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (2/3). $ARGX Phase X $INCY Phase X $WVE Phase X $EWTX Phase X $RNAC Phase X $ROIV Phase X $GLPG Phase X $MGNX Phase X $BHVN Phase X $ANRO Phase X $PRAX Phase 2/3 $BHVN Phase X $COGT Phase X $ALKS Phase X $MRUS Phase X $MRUS Phase X $MRUS Phase X $ZNTL Phase X $IOVA Phase X $IOVA Phase X $AVXL Phase X $BBIO Phase X $GNLX Phase X $COYA Phase X $RXRX Phase X $PRTA Phase X $VALN Phase X $CGON Phase X $GNLX Phase X $EXEL Phase X $COGT Phase X $PCSA Phase X $IMVT Phase X $BMEA Phase X $EXEL Phase X $JAZZ Phase X $HOOK Phase X $ANRO"
X Link @BiopharmIQ 2025-09-28T19:33Z 27.3K followers, XXX engagements

"🧬 Biotech Stock News 10/7 Brought to you by Barb On the rise 📈 $LXEO XX% $TELO XX% $KZIA XX% Under pressure 📉 $CLRB -XX% $HUMA -XX% $BMEA -XX% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-10-07T18:46Z 27.3K followers, 3479 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (3/3). $RARE Phase X $GPCR Phase 2b $ZBIO Phase X $ADCT Phase X $AGIO Phase X $SLS Phase X $PCVX Phase X $ARTV Phase 2a $ALZN Phase X $IMMP Phase 2/3 $ALDX Phase X $TLPH Phase X $INAB Phase X $ALNY Phase X $LLY Phase X $BBIO Phase X $FBIO Phase X $IONS Phase X $REGN Phase 2/3 $CALT Phase X $JAZZ Phase X $GNFT Phase X $NAMS Phase X $PBYI Phase X $KZIA Phase X $NVS Phase X $NAMS Phase X $MRNA Phase X $DNLI Phase 2/3 $LSTA Phase 2b $INKT Phase X $STOK Phase X $ADAG Phase X $PBYI Phase X $ALDX Phase X $CNTA Phase 2a $RLMD Phase 2"
X Link @BiopharmIQ 2025-10-05T20:24Z 27.3K followers, 1142 engagements

"📌 Biotech Stock News 10/13 @ Midday $CGEN XX% COM701 Pooled Analysis $RCUS X% Median OS Data in Ph2 Study $ANAB X% Late-Breaking Presentation at ACR $BCAX X% Ficerafusp Alfa Granted Breakthrough Designation $MNKD X% FDA Review for Inhaled Insulin in Youth $ADGM X% Preliminary Acute Results from FULCRUM-VT $ONC X% Sonrotoclax Breakthrough Therapy Designation $CGEM X% Present Zipalertinib Data at ESMO $HCM X% FRUSICA-2 Registration Trial Data at ESMO $NTRA X% IMvigor011 Oral Presentation at ESMO $APGE X% Closed $345M Public Offering $MRNA X% Cancer Antigen Therapy Data at ESMO $EVAX X% EVX-01"
X Link @BiopharmIQ 2025-10-13T16:58Z 27.3K followers, 9105 engagements

"🧬 Biotech Weekly News 9/8/25 - 9/12/25 Major Movers 📈 $RAPP XXX% Topline Data RAP-219 Ph2a Trial $TRML XX% Novartis Acquires Tourmaline Bio $MAZE XX% MZE782 Ph1 Trial Results $TVTX XX% FDA AdCom Meeting Update $ONCY XX% Highlights Data in CRC 📉 $SMMT -XX% Longer-Term Data in NSCLC $ACTU -XX% Pricing $15M Public Offering $IDYA -XX% Multiple Trial Readouts $NUVB -XX% New Data from NSCLC Studies $TIL -XX% Presentation 2510 Monotherapy Data ***** Impressive data drop from $RAPP 🔥 RAP-219 - strong seizure reduction in Focal Onset Epilepsy See @PersimmonTI post below. $XBI"
X Link @BiopharmIQ 2025-09-12T22:44Z 27.3K followers, 11.2K engagements

"📌 Biotech Stock News 10/01 @ Open $PALI XX% Pricing of $120M Public Offering $ACOG XX% Pricing of $35M Public Offering $CPRX XX% $200M Share Repurchase Program $ARVN X% Present ARV-102 Data at MDS '25 $PHAR X% sNDA Acceptance & Priority Review for Leniolisib $AZN X% BLA Accepted for Enhertu $ILMN X% Secures $23.4M for Diagnostic Platform $TMO X% Prices Offering of Senior Notes $KURA X% Clinical Trial for AML Treatment $ADGM X% Completion of Enrollment for Trial $BMY X% Anti-Tau Antibody Granted Fast Track $ABBV X% $70M Manuf Expansion $CRSP X% Present Preclin Data on AATD at ESGCT $CCCC 2%"
X Link @BiopharmIQ 2025-10-01T16:29Z 27.3K followers, 7800 engagements

"📌 Biotech Stock News 10/08 @ Open $EVAX XX% Expands AI-Immunology Platform $ATXS X% Navenibart Ph3 Trial Initiation $SPRY X% Favorable Patent Decision on neffy $LSTA X% Global ADC License Agreement $AARD X% FDA Alignment on Protocol Amendment $TRVI X% Oral Presentation at CHEST 2025 $AQST X% Broadens Patent Estate for Anaphylm $HOWL X% Fast Track Designation for WTX-124 $OSTX -X% Participation in Fall 2025 Conferences $IVA -X% Presenting Multiple Abstracts at AASLD $ZBIO -X% License Agreement for Autoimmune Candidates $VRCA -X% New Data on VP-315 for BCC $RIGL -X% First Patient Enrolled in"
X Link @BiopharmIQ 2025-10-08T15:45Z 27.3K followers, 7750 engagements

"🧬 Biotech Weekly News 9/29/25 - 10/03/25 Major Movers 📈 $ENTA XX% Ph2b Study Results in RSV $ANRO XX% ALTO-101 FDA FTD Granted $TSHA XX% TSHA-102 FDA BTD Granted $ANAB XX% Separates Biopharma Operations $VOR XX% Late-Breaking Poster Presentation at ACR 📉 $MLTX -XX% 16-wk Results of VELA program $KALA -XX% Ph2b CHASE Topline Results $APLT -XX% Update Following Meeting w/ FDA $LRMR -XX% Long-Term Data from OLE Study $FBIO -XX% Update on NDA for CUTX-101 ***** $ENTA Fresh insights from @EnantaPharmas leadership on RSV data for Zelicapavir What it means now and whats next for the program."
X Link @BiopharmIQ 2025-10-03T22:32Z 27.3K followers, 28.8K engagements

"🧬 Biotech Stock News 10/14 @ Open $ATXS XX% BCRX Acquires ATXS $RCKT XX% FDA Acceptance of BLA Resubmission $GNPX XX% Preclinical Data on Gene Therapy $RNAZ XX% Prelim Data from Ph1a Study $SYRE X% $275M Public Offering $TELO X% New Data on Telomir-1 and Cancer $ZYME X% Clinical Data from Ph1 Trial $AMRN X% Collaboration on REDUCE-IT Presentation $IMNN X% Ph3 Ovarian Cancer Study Presentation $TBPH X% New Analyses on YUPELRI Outcomes in COPD $TNXP X% Update on Fc-modified anti-CD40L mAb $MCRB X% Post Hoc Data from SER-155 Trial $CORT X% MAA Submitted for Relacorilant $LXRX X% Additional"
X Link @BiopharmIQ 2025-10-14T16:02Z 27.3K followers, 10.6K engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $LQDA Phase X $IFRX Phase 2a $IFRX Phase 2b $PTGX Phase 2b $EVAX Phase X $DCTH Phase X $CELC Phase X $IDYA Phase X $IDYA Phase 2/3 $KYTX Phase X $VOR Phase X $ATAI Phase 2b $INBX Phase X $KZR Phase 2a $PROK Phase X $ELDN Phase X $PVLA Phase X $NKTR Phase 2b $RZLT Phase X $RCUS Phase X $ASMB Phase X $BDTX Phase X $RNA Phase X $CAPR Phase X $TARA Phase X $ZVSA Phase 2a $CGON Phase X $VTYX Phase X $DBVT Phase X $PHVS Phase X $VTGN Phase X $TERN Phase X $ALEC Phase X $ZBIO Phase X $IRON Phase X $INBX Phase 2/3 $MLTX Phase 2"
X Link @BiopharmIQ 2025-09-28T19:33Z 27.3K followers, 40.8K engagements

"$INCY ✅ FDA clears Incytes Opzelura for kids XXX with atopic dermatitis First topical JAK inhibitor approved in the U.S. for pediatric AD sNDA based on Phase X TRuE-AD3 trial - primary & secondary endpoints met - higher treatment success (IGA-TS) vs vehicle - more achieved EASI-75 at Wk X - no new safety concerns"
X Link @BiopharmIQ 2025-09-19T15:03Z 27.3K followers, 6366 engagements

"Let's see how many of the XX biopharma-focused hedge funds hold these tickers. $IDYA 5/34 🔥 $JAZZ 4/34 $INBX 3/34 Access our FREE hedge fund screener & search your fav tickers"
X Link @BiopharmIQ 2025-10-12T20:36Z 27.3K followers, 2110 engagements

"🧬 Biotech Stock News 10/10 Brought to you by Barb On the rise 📈 $CDTX X% Under pressure 📉 $QNCX -X% $CABA -X% $ANVS -XX% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-10-10T17:28Z 27.3K followers, 3043 engagements

"📌 Biotech Stock News 10/10 @ Open $CDTX X% Present @ 10th ESWI Influenza Conf. $AZN X% Expand VA Manuf. Facility $OSTX X% OST-HER2 Ph2b OS Data $JNJ X% MDD Portfolio @ 2025 ECNP Congress $CRSP X% New Preclinical CTX460 Data $BIIB -X% New Zorevunersen Data @ 54th CNS Mtg. $BMY -X% To Acquire Orbital Therapeutics $ASMB -X% ABI-5366 Interim Ph1b Data @ IUSTI-EU $VIR -X% First Participant Dosed for VIR-5500 Trial $QNCX -X% Present Data @ 54th CNS Mtg. $CABA -X% Rese-cel Data @ ESGCT'25 $ANVS -XX% $6M Direct Offering See the image and comments for more details"
X Link @BiopharmIQ 2025-10-10T15:53Z 27.3K followers, 7729 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (2/3). $IMVT Phase X $HOOK Phase X $GNLX Phase X $GNLX Phase X $GLPG Phase X $EXEL Phase X $EXEL Phase X $EWTX Phase X $COYA Phase X $COGT Phase X $COGT Phase X $CGON Phase X $RNAC Phase X $BBIO Phase X $BMEA Phase X $BINV Phase 2a $BHVN Phase X $BHVN Phase X $ARGX Phase X $AMGN Phase X $ANRO Phase X $ANRO Phase 2b $ALKS Phase X $ELDN Phase X $ACLX Phase X $BIVI Phase 2b $KPTI Phase X $CRVS Phase X $ZVSA Phase 2a $ZBIO Phase X $VTGN Phase X $VTYX Phase X $VTYX Phase X $TERN Phase X $TARA Phase X $PHVS Phase X $MLTX Phase X $MBRX"
X Link @BiopharmIQ 2025-10-12T20:36Z 27.3K followers, XXX engagements

"🧬 Biotech Weekly News 9/2/25 - 9/5/25 Major Movers 📈 $CYTK XX% Presented New Aficamten Data $IONS XX% Olezarsen Landmark Trials Results $UTHR XX% TETON-2 Study Met Endpoint $AQST XX% FDA Will Not Require AdCom $OLMA XX% New Trial for Breast Cancer 📉 $WVE -XX% RestorAATion-2 Trial Update $THAR -XX% Presentations on TH104 $PMN -XX% DSMB Approval for Ph1b Trial $AGIO -XX% Update on PDUFA Goal Date $MBX -XX% Doses First Patient in Ph1 ****** X asset. Multiple shots on goal 💊 $CYTK aficamten looks like the rare true pipeline-in-a-pill A franchise play unfolding fast. Dont miss @BowTiedBiotechs"
X Link @BiopharmIQ 2025-09-05T22:57Z 27.3K followers, 13.7K engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $LQDA Phase X $ATAI Phase 2b $EVAX Phase X $DCTH Phase X $CELC Phase X $SVRA Phase X $IDYA Phase X $IDYA Phase 2/3 $KYTX Phase X $INBX Phase X $VOR Phase X $JAGX Phase X $ALXO Phase X $PROK Phase X $VRCA Phase X $KZR Phase 2a $OSTX Phase 2b $ELDN Phase X $IFRX Phase 2a $IFRX Phase 2b $RZLT Phase X $NKTR Phase 2b $PVLA Phase X $PRAX Phase X $ASMB Phase X $RCUS Phase X $ZNTL Phase X $WVE Phase X $VALN Phase X $ROIV Phase X $RYTM Phase X $RXRX Phase X $RAPT Phase X $PRTA Phase X $PCSA Phase X $PRAX Phase 2/3 $MRUS Phase 2"
X Link @BiopharmIQ 2025-10-12T20:36Z 27.3K followers, 32.3K engagements

"🧬 Biotech Weekly News 06/02/25 - 06/06/25 Major Movers 📈 📉 $LYRA XXX% Positive Results ENLIGHTEN X Trial $VERA XX% Atacicept XX% Proteinuria Reduction $KYMR XX% Positive Ph1 First-in-Human Results $BPMC XX% Sanofi to acquire Blueprint Medicines $AGEN XX% Strategic Collab. to Advance BOT/BAL $XLO -XX% Updated Ph2 Data for Vilastobart $VSTM -XX% Updated Data from Ph1 Study $RGNX -XX% Data from Ph2/3 Trial $ACTU -XX% Elraglusib Highlights from KOL Event $ANAB -XX% Rosnilimab Data in RA Trial See image below. 📸 💭 $VERA strong Phase X data in IgAN definitely one to watch. The big question:"
X Link @BiopharmIQ 2025-06-06T22:55Z 27.3K followers, 9664 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (2/3). $WVE Phase X $EWTX Phase X $RNAC Phase X $ROIV Phase X $GLPG Phase X $MGNX Phase X $BHVN Phase X $ANRO Phase X $PRAX Phase 2/3 $BHVN Phase X $COGT Phase X $ALKS Phase X $MRUS Phase X $MRUS Phase X $MRUS Phase X $ZNTL Phase X $IOVA Phase X $IOVA Phase X $BBIO Phase X $GNLX Phase X $COYA Phase X $RXRX Phase X $PRTA Phase X $VALN Phase X $CGON Phase X $GNLX Phase X $EXEL Phase X $COGT Phase X $PCSA Phase X $IMVT Phase X $BMEA Phase X $EXEL Phase X $JAZZ Phase X $HOOK Phase X $ANRO Phase 2b $RYTM Phase X $AMGN Phase X $INCY"
X Link @BiopharmIQ 2025-10-05T20:24Z 27.3K followers, 1055 engagements

"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q3 2025. $NAMS Phase 2a $CGTX Phase X $CRDF Phase X $DMAC Phase X $IXHL Phase X $ENTX Phase X $MLTX Phase X $LRMR Phase X $RAPP Phase 2a $PMVP Phase X $ATAI Phase 2b $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $VYNE Phase 2b $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $INMB Phase X $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $FDMT Phase X $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $BTAI Phase X $PRAX Phase X $ATYR Phase X $FBIO Phase X $UPB Phase 2"
X Link @BiopharmIQ 2025-07-13T18:07Z 27.3K followers, 40K engagements

"BioCryst $BCRX to Acquire Astria Therapeutics $ATXS 👇"
X Link @BiopharmIQ 2025-10-14T16:02Z 27.3K followers, 2139 engagements

"📣 Biotech Stock News 10/15 @ Open $OMER XXX% Asset purchase & license agreement $APLM XX% Resumes Trading $SPRC XX% Acquisition Agreement $ABSI XX% KOL Seminar on ABS-201 Program $XNCR X% Ph1 Dose-Escalation Results Presented $GYRE X% Completion of Patient Enrollment in Trial $SCYX X% Disagreement Resolved on Phase X Study $NVCR X% New Research for TTFields Therapy $HIMS X% Launches Menopause & Perimenopause Specialty $TEM X% Six Abstracts Accepted for ESMO 2025 $MNPR X% Abstract Accepted for Oral Presentation $ACOG X% Presenting Clinical Data at Meetings $AUPH X% Upcoming Presentations on"
X Link @BiopharmIQ 2025-10-15T15:42Z 27.3K followers, 6636 engagements

"$TEVA -X% 📉 FDA Approves Expanded Indication for Uzedy once-monthly extended-release injectable suspension for Bipolar I disorder (BD-I) in adults Access our free PDUFA report for more info: 👇 FDA CRLs/Approvals Prior Adcoms More"
X Link @BiopharmIQ 2025-10-13T16:58Z 27.3K followers, 1497 engagements

"🧬 Biotech Stock News 10/3 Brought to you by Barb On the rise 📈 $ANRO XX% $OVID XX% $ALXO X% Under pressure 📉 $AKTX -X% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-10-03T17:11Z 27.3K followers, 3142 engagements

"🧬 Biotech Stock News 09/24 Brought to you by Barb On the rise 📈 $QURE198% $CDTX17% $AKTX13% Under pressure 📉 $BIIB -X% $HRMY -XX% $ACAD-11% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-09-24T17:40Z 27.3K followers, 4067 engagements

"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% $IDYA Darovasertib + crizotinib $JAZZ Zanidatamab $INBX Ozekibart (INBRX-109) Access our FREE Big Mover Report"
X Link @BiopharmIQ 2025-10-12T20:36Z 27.3K followers, 2149 engagements

"💰 $BMY to acquire Orbital Tx Adds OTX-201 an in vivo CAR-T Extends $BMY s cell tx into autoimmune diseases Check out our free biopharma M&A tracker: 👇 Provides info on past M&A activity"
X Link @BiopharmIQ 2025-10-10T15:54Z 27.3K followers, 1304 engagements

"📢 M&A News: BioCryst $BCRX to Acquire Astria Therapeutics $ATXS 💵 Cash-and-stock deal valued at about $700m 📈 $13/sh (53% premium over ATXS last close) 💉 Adds navenibart long-acting injectable for HAE currently in Ph3 🤝 To close in Q1 2026 See image for more info 👇"
X Link @BiopharmIQ 2025-10-14T14:49Z 27.3K followers, 5193 engagements

"Let's see how many of the XX biopharma-focused hedge funds hold these tickers. $ADVM 3/34 $VTYX 3/34 $BDTX 2/34 Access our FREE hedge fund screener & search your fav tickers"
X Link @BiopharmIQ 2025-10-05T20:24Z 27.3K followers, 2320 engagements

"📌 Biotech Stock News 10/3 @ Open $ANRO XX% ALTO-101 FDA Fast Track Designation $OVID XX% OV329 Data & $175M Private Placement $ALXO X% ASPEN-06 Ph2 Trial Update $CDTX X% BARDA Award for CD388 Development $EVAX X% EVX-01 New biomarker data @ SITC'25 $CADL X% Presentation @ SITC Meeting $ENTA X% Closing of Upsized Public Offering $BCAB X% Mecbotamab Vedotin Data @ SITC'25 $HOWL X% Posters @ SITC'25 $XLO X% Presentation @ SITC Meeting $JAZZ X% FDA Approves Zepzelca+Atezolizumab $SRPT X% New Data @ WMSC'25 $CHRS X% Poster Presentation @ SITC'25 $PALI X% Closing of $138M Offering $RHHBY X% FDA"
X Link @BiopharmIQ 2025-10-03T15:47Z 27.3K followers, 9673 engagements

"Baker Bros. 🔔🐳 Q2 25* Holdings Released Holdings: XX Holdings in Top 20: XX% Qtr over Qtr Change**: XXXXX% Top Holdings 🚀: $ONC $INCY $ACAD $INSM $SMMT $MDGL $RYTM $RVMD $KYMR $ALKS $REPL $RARE $EWTX $ABCL $IMVT $GRAL $KNSA $BCYC $IMCR $CELC *Holdings as of 6/30/25 in SEC form 13F **Change in value of public company shares held See image for more details 👇"
X Link @BiopharmIQ 2025-08-14T22:20Z 27.3K followers, 15.6K engagements

"🧬 Biotech Stock News 10/9 Brought to you by Barb On the rise 📈 $TELO XX% $AKRO XX% $NGNE XX% Under pressure 📉 $EDIT -X% $LPTX -X% $ACXP -X% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-10-09T18:22Z 27.3K followers, 3698 engagements

"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q3 2025. $NAMS Phase 2a $CRDF Phase X $IXHL Phase X $ENTX Phase X $MLTX Phase X $LRMR Phase X $KAPA Phase X $RAPP Phase 2a $PMVP Phase X $ATAI Phase 2b $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $VYNE Phase 2b $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $FDMT Phase X $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $BTAI Phase X $PRAX Phase X $ATYR Phase X $FBIO Phase X $UPB Phase X $INMB Phase X $IFRX Phase 2a"
X Link @BiopharmIQ 2025-07-20T20:51Z 27.3K followers, 38.2K engagements

"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q3 2025. $PHVS Phase X $PHVS Phase X $NAMS Phase 2a $CGTX Phase X $DMAC Phase X $COGT Phase X $ENTX Phase X $MLTX Phase X $LRMR Phase X $RAPP Phase 2a $PMVP Phase X $ATAI Phase 2b $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $VYNE Phase 2b $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $APGE Phase X $INMB Phase X $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $FDMT Phase X $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $BTAI Phase X $PRAX Phase X $ATYR Phase 3"
X Link @BiopharmIQ 2025-07-06T18:36Z 27.3K followers, 55.7K engagements

"📣 Biotech Stock News 09/23 @ Open $ATAI XX% Positive Ph2a Data for BPL-003 $GRAL X% Data Presentation at ESMO $PROF X% Launch of First TULSA Program $LXRX X% Update on FDA Submission for Zynquista $SLDB X% Licensing Agreement for Next-Gen Capsid $IOBT X% Late-Breaking Abstract in Advanced Melanoma $SCLX X% Closing of Business Combination Announced $CORT X% New Data From ROSELLA Trial $SNSE X% Virtual KOL Event on Dose Expansion Data $JAGX X% Updates at Upcoming Conferences $DGX X% Improve Laboratory Testing Experience $BMY X% Phase X Study Shows Improved Outcomes $AMRX X% U.S. FDA Approval"
X Link @BiopharmIQ 2025-09-23T16:10Z 27.3K followers, 6537 engagements

"🧬 Biotech Stock News 09/09 Brought to you by Barb X on the rise 📈 $TRML XX% $TELO XX% $XLO XX% X under pressure 📉 $TXG -X% $CTXR -X% $RAPP -XX% Catch the full breakdown in the latest video 🎥"
X Link @BiopharmIQ 2025-09-09T17:25Z 27.3K followers, 3509 engagements

"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% $ADVM Ixoberogene soroparvovec (Ixo-vec) $VTYX VTX2735 $BDTX BDTX-1535 Access our FREE Big Mover Report"
X Link @BiopharmIQ 2025-10-05T20:24Z 27.3K followers, 2441 engagements

"📢 M&A News: Genmab $GMAB to acquire Merus $MRUS for $8B 💰 $97/share all-cash (41% premium $8B EV) 🧬 Adds Phase X bispecific petosemtamab (BTD in head & neck cancer) Ph2 data showed strong ORR & PFS SOC; Ph3 readouts in 2026 Expected launch 2027 $1B sales by 2029 multi-billion potential longer term 🗓 Closing by Q1 2026 See photo for more info 👇"
X Link @BiopharmIQ 2025-09-29T14:40Z 27.3K followers, 10.4K engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (3/3). $ALT Phase 2b $ALEC Phase X $ADVM Phase X $ZBIO Phase X $PCVX Phase X $RARE Phase X $TRAW Phase X $GPCR Phase 2b $SLS Phase X $RHHBY Phase X $MREO Phase X $KMDA Phase X $INSM Phase X $ATOS Phase X $ARTV Phase 2a $ALZN Phase X $AGIO Phase X $ADCT Phase X $TLPH Phase X $STOK Phase X $RLMD Phase X $REGN Phase 2/3 $PBYI Phase X $PBYI Phase X $NVS Phase X $NAMS Phase X $NAMS Phase X $NAMS Phase X $MRNA Phase X $INKT Phase X $LSTA Phase 2b $KZIA Phase X $JAZZ Phase X $IONS Phase X $INAB Phase X $IMMP Phase 2/3 $GNFT Phase X $FBIO"
X Link @BiopharmIQ 2025-10-12T20:36Z 27.3K followers, XXX engagements

"📣 Biotech Stock News 09/09 @ Open $TRML XX% Novartis Acquires Tourmaline Bio $TELO XX% New Cancer Data on Prostate Cells $XLO XX% Initiation of Phase X Trial $MBRX X% Accelerates Recruitment in Phase X Trial $AGEN X% Reimbursed Compassionate Access for BOT/BAL $DNTH X% Proposed $XXX Million Public Offering $NKGN X% Completion of Acquisition and Control $NKTR X% REZOLVE-AD Phase 2b Results Presented $AVXL X% Cognitive Resilience Results in Alzheimer's Trial $IONS X% FDA Breakthrough Therapy designation for ION582 $EVFM X% Anticipates Merger Approval at Meeting $ACRS X% Late-Breaking Abstract"
X Link @BiopharmIQ 2025-09-09T15:46Z 27.3K followers, 9868 engagements

"Biotech Stock Catalyst Watchlist 🎯 Ph2 & Ph3 readouts in Q3 2025. $UTHR Phase X $ARCT Phase X $MLTX Phase X $QURE Phase 2/3 $ENTA Phase X $KALA Phase 2b $LTRN Phase X $LRMR Phase X $ENTX Phase X $MTSR Phase 2b $ATAI Phase 2b $GRI Phase 2a $HRMY Phase X $CLNN Phase X $NKTR Phase X $FBIO Phase X $LGVN Phase 2a $SKYE Phase 2a $PRAX Phase X Check out the image for more details"
X Link @BiopharmIQ 2025-09-21T19:05Z 27.3K followers, 52.4K engagements

"October Biotech PDUFA Pulse: 📡 Whats on the FDA Radar $JAZZ - Zepzelca + Tecentriq - Approved $ARQT - ZORYVE (roflumilast) Cream XXXX% $AMGN - Tezspire $GKOS - Epioxa (Epi-on) $GSK - Blenrep combinations (BVd & BPd) $SNDX - Revuforj (revumenib) $MRK - WINREVAIR (sotatercept-csrk) $RHHBY - Gazyva/Gazyvaro $REGN - Libtayo (cemiplimab) Check out this months PDUFA calendar"
X Link @BiopharmIQ 2025-10-03T16:10Z 27.3K followers, 16.8K engagements

"Exciting Q4 2023 BPIQ Big & Suspected Movers $EVAX $ACRS $CMPX And more See our free report of stock-moving catalysts to watch coming this quarter 🎉 👇"
X Link @BiopharmIQ 2025-10-08T15:45Z 27.3K followers, 2543 engagements

"$RCKT XX% 📈 FDA Acceptance of BLA Resubmission KRESLADI a lentiviral vector (LV)-based gene tx for severe LAD-I PDUFA target action date March XX 2026 🎯 Access our free PDUFA report for more info: 👇 FDA CRLs/Approvals Prior Adcoms"
X Link @BiopharmIQ 2025-10-14T16:02Z 27.3K followers, 1170 engagements

"🧬 Biopharma Weekly Recap 📝 This week in biotech: Novos $5.2B acquisition reshapes the GLP-1 rivalry rare-disease micro-caps soar AI and gene-editing deals accelerate and IBD drugs dominate headlines. @DueDoctor Rare disease biotechs: small stakes big moves: $SPRB +648% @A_May_MD THIS IS 🚨NOT🚨 A PITCH but the $PALI story is a fascinating one. @Biotech2k1 $SPRB: MPS3 $250750M potential BTD filing Q1 XX 5x upside if mgmt delivers. @BiopharmIQ Ph2 & Ph3 readouts in Q4 2025 @davidycli Only two types of founders getting funded right now in biotech @JKeynesAlpha $RXRX 🔥🔥🔥Recursion seems"
X Link @BiopharmIQ 2025-10-11T20:44Z 27.3K followers, 22.8K engagements

"📢M&A News: Novo Nordisk to acquire Akero Therapeutics for up to $5.2B 🚨 💰 $54/share cash + $6/share CVR tied to FDA approval of efruxifermin for MASH cirrhosis 📈 XX% premium to Akeros pre-deal price 🧬 Adds Phase X FGF21 analog EFX to Novos metabolic portfolio 🗓 Deal closes by YE 2025 pending approvals 🤔 Signals renewed M&A momentum in MASH/NASH. Validates FGF21 pathway.potential re-rating for peers like $VKTX $TERN See image for more details"
X Link @BiopharmIQ 2025-10-09T15:06Z 27.3K followers, 15.9K engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $PTGX Phase 2b $EVAX Phase X $DCTH Phase X $CELC Phase X $IDYA Phase X $IDYA Phase 2/3 $KYTX Phase X $VOR Phase X $INBX Phase X $ATAI Phase 2b $LQDA Phase X $PROK Phase X $KZR Phase 2a $ALXO Phase X $ELDN Phase X $IFRX Phase 2a $IFRX Phase 2b $NKTR Phase 2b $RZLT Phase X $PVLA Phase X $BDTX Phase X $RNA Phase X $CAPR Phase X $TARA Phase X $ZVSA Phase 2a $CGON Phase X $VTYX Phase X $DBVT Phase X $PHVS Phase X $VTGN Phase X $TERN Phase X $ALEC Phase X $ZBIO Phase X $IRON Phase X $INBX Phase 2/3 $MLTX Phase X $ANAB Phase 2"
X Link @BiopharmIQ 2025-10-05T20:24Z 27.3K followers, 54.8K engagements

"📌 Biotech Stock News 07/30 🧬 📽 $VRDN XX% Collaboration & License Agreement w/ Kissei Pharma $IMNN X% First Patient Dosed in Ph3 Study $CELC X% Pricing of Public Offering $MIRA X% Topical Ketamir-2 Preclin Data $ACRS X% Results from ATI-2138 Ph2a Trial $CRBP X% CRB- XXX Ph1/2 Clinical Data at ESMO $TNYA X% Safety Reviews for Gene Trials $LRMR X% Pricing of Public Offering $ABBV X% Ph3 Topline Results from Alopecia Trial $BIIB X% New Data on Leqembi at AAIC $NAMS X% Data from BROADWAY Trial at AAIC $SNSE X% Clinical Data from Phase X Cohort at ESMO $MDGL X% Exclusive Global License for GLP-1"
X Link @BiopharmIQ 2025-07-30T21:29Z 27.3K followers, 3529 engagements

"Step 3: Focus on the Intersection ✅ Major near-term catalysts ✅ Strong hedge fund presence From this list $DYN (13) $COGT (11) $CRNX (8) and $CGON (8) stand out as both catalyst-rich and heavily owned by funds. 📈 These could be worth adding to your watchlist 👀"
X Link @BiopharmIQ 2025-08-15T21:38Z 27.3K followers, 1759 engagements

"📌 Biotech Stock News 8/11 @ Open 🔔 $IMAB XX% Enrollment Completed in Ph1b Study $TLSA XX% Ph2 IND Approval $AMPH XX% Approval for Iron Sucrose Injection $ARVN X% NDA for Vepdegestrant Accepted $KMDA X% FDA Approval of Plasma Collection Center $INO X% INO-3107 Long-Term Surgery Reduction $NVS X% Ianalumab Ph3 Trials Met Endpoint $OCGN X% $20M Direct Offering Announced $NRXP X% Fast Track Designation for NRX-100 $BIIB X% First Patient Dosed in Ph3 Study $LGVN -X% $17.5M Public Offering $PTN -X% 1-for-50 Reverse Stock Split $VERU -X% Modified Release Oral Enobosarm for Clinical Study $IOBT"
X Link @BiopharmIQ 2025-08-11T15:36Z 27.3K followers, 7221 engagements

"🧬 Biotech Stock News 08/11 Brought to you by Barb X stocks on the rise 📈 $IMAB $TLSA $AMPH X under pressure 📉 $PTN $VERU $IOBT Catch the full breakdown in the latest video 🎥"
X Link @BiopharmIQ 2025-08-11T16:31Z 27.3K followers, 3627 engagements